 |
市場調査レポート
商品コード
1360428
迅速医療診断キットの世界市場の規模、シェア、成長分析：製品別、最終用途別 - 産業予測（2023年～2030年）Global Rapid Medical Diagnostic Kits Market Size, Share, Growth Analysis, By Product(Over the Counter (OTC) Kits, and Professional Kits), By End use(Hospitals & Clinics, Home Care) - Industry Forecast 2023-2030 |
||||||
| 迅速医療診断キットの世界市場の規模、シェア、成長分析：製品別、最終用途別 - 産業予測（2023年～2030年） |
|
出版日: 2023年09月13日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の迅速医療診断キットの市場規模は、2022年の161億3,000万米ドルから2030年までに210億8,000万米ドルに達し、予測期間（2023年～2030年）にCAGRで3.4％の成長が予測されています。
市場成長の主な促進要因は、ポイントオブケア診断に対する需要の高まり、感染症の発生、即座の医療インサイトの必要性などです。技術の進歩と医療意識の高まりにより、市場は持続的な成長を示すと予測されます。
促進要因
COVID-19、インフルエンザ、HIV、性感染症などの伝染性疾患の発生が急増しているため、迅速医療診断キットのニーズが高まっています。
抑制要因
厳しい規制基準
迅速医療診断キットは、その安全性、正確性、信頼性を保証するために、厳格な規制基準を満たすことが義務付けられています。必要な規制基準の承認と遵守の維持には時間と資金がかかるため、特に小規模メーカーにとっては市場参入の障害となります。
市場動向
市場では、携帯式のユーザーフレンドリーな迅速診断ツールの開発が重視されています。これらの機器は、特に資源が限られた地域や遠隔地での検査を容易にします。ユーザーフレンドリーなインターフェースと明解な説明書が組み込まれることで、医療従事者とエンドユーザーの双方にとって、これらのツールのアクセシビリティとユーザビリティが向上します。
当レポートでは、世界の迅速医療診断キット市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界の迅速医療診断キット市場：製品別
- 市場の概要
- OTCキット
- 業務用キット
世界の迅速医療診断キット市場：最終用途別
- 市場の概要
- 病院・クリニック
- 在宅ケア
- 診断研究所
世界の迅速医療診断キットの市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Abbott Laboratories - USA
- Becton, Dickinson and Company (BD) - USA
- BioMerieux - France
- Cepheid (A Danaher Company) - USA
- Chembio Diagnostic Systems, Inc. - USA
- CTK Biotech - USA
- Diasorin S.p.A. - Italy
- F. Hoffmann-La Roche Ltd. - Switzerland
- Hologic, Inc. - USA
- Luminex Corporation - USA
- Meridian Bioscience, Inc. - USA
- OraSure Technologies, Inc. - USA
- PerkinElmer, Inc. - USA
- QIAGEN N.V. - Netherlands
- Siemens Healthineers AG - Germany
- Sysmex Corporation - Japan
- Thermo Fisher Scientific Inc. - USA
- Trinity Biotech - Ireland
- Quidel Corporation - USA
- Zybio Inc. - China
Market Insights
Global Rapid Medical Diagnostic Kits Market size was valued at USD 15.6 Billion in 2021 and is poised to grow from USD 16.13 Billion in 2022 to USD 21.08 Billion by 2030, at a CAGR of 3.4% during the forecast period (2023-2030).
The Global Rapid Medical Diagnostic Kits Market comprises innovative tools that swiftly detect various medical conditions. These kits offer quick and accurate results, enhancing patient care and disease management. Key factors driving market growth include the rising demand for point-of-care diagnostics, infectious disease outbreaks, and the need for immediate medical insights. With expanding technological advancements and increasing healthcare awareness, the market for rapid medical diagnostic kits is projected to experience sustained growth.
Top-down and bottom-up approaches were used to estimate and validate the size of rapid medical diagnostic kits and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segmental Analysis
The global rapid medical diagnostic kits market is segmented on the basis of product, end use, and region. By product, the market is segmented into Over the Counter (OTC) Kits and Professional Kits. By end use, the market is segmented into Hospitals & Clinics, Home Care, and Diagnostic Laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers
The escalating occurrence of contagious ailments like COVID-19, flu, HIV, and sexually transmitted infections has generated an amplified need for swift medical diagnostic kits. Such kits allow prompt and precise pathogen identification, aiding in the early detection and control of diseases.
Restraints
Demanding Regulatory Standards:
Rapid medical diagnostic kits are obligated to meet rigorous regulatory criteria to guarantee their safety, precision, and dependability. Acquiring necessary regulatory endorsements and upholding adherence can consume time and financial resources, posing an impediment to market access, particularly for smaller producers.
Market Trends
Emphasis is shifting towards the creation of portable and user-friendly rapid diagnostic tools in the Global Rapid Medical Diagnostic Kits Market. These devices facilitate on-the-spot testing, especially in areas with limited resources and remote locations. The incorporation of user-friendly interfaces and clear instructions improves the accessibility and usability of these tools for both medical practitioners and end-users.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Rapid Medical Diagnostic Kits Market by Product
- Market Overview
- Over the Counter (OTC) Kits
- and Professional Kits
- Global Rapid Medical Diagnostic Kits Market by End use
- Market Overview
- Hospitals & Clinics
- Home Care
- and Diagnostic Laboratories
- Global Rapid Medical Diagnostic Kits Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Abbott Laboratories - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (BD) - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioMerieux - France
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cepheid (A Danaher Company) - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Chembio Diagnostic Systems, Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CTK Biotech - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Diasorin S.p.A. - Italy
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd. - Switzerland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hologic, Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Luminex Corporation - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Meridian Bioscience, Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OraSure Technologies, Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer, Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN N.V. - Netherlands
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG - Germany
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sysmex Corporation - Japan
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Trinity Biotech - Ireland
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quidel Corporation - USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zybio Inc. - China
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
